Total medical devices industry M&A deals worth $21.21bn were announced in the US in January 2021, with OptumInsight’s $13bn acquisition of Change Healthcare being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 238.8% over the previous month of $6.26bn and a rise of 307.1% when compared with the last 12-month average of $5.21bn.
The US held a 91.19% share of the global medical devices industry M&A deal value that totalled $23.26bn in January 2021.
In terms of M&A deal activity, the US recorded 25 deals during January 2021, marking a decrease of 19.35% over the previous month and a rise of 25.00% over the 12-month average.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataUS medical devices industry M&A deals in January 2021: Top deals
The top five medical devices industry M&A deals accounted for 94.3% of the overall value during January 2021.
The combined value of the top five medical devices M&A deals stood at $20.01bn, against the overall value of $21.21bn recorded for the month.
The top five medical devices industry M&A deals of January 2021 tracked by GlobalData were:
1) OptumInsight’s $13bn acquisition of Change Healthcare
2) The $4.6bn acquisition of Cantel Medical by Steris
3) Boston Scientific’ $1.23bn acquisition of Preventice.
4) The $635m acquisition of Capsule Technologies by Koninklijke Philips
5) Thermo Fisher Scientific’s acquisition of Mesa Biotech for $550m.
